926 results on '"Youdim, Moussa B. H."'
Search Results
2. Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
3. Neuroprotection and Neurorestoration of Nigra Striatal Dopamine Neurons by Novel Multitarget Drugs, M30
4. From Anti-Parkinson’s Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer’s Disease
5. Site-activated multi target iron chelators with acetylcholinesterase (AChE) and monoamine oxidase (MAO) inhibitory activities for Alzheimer’s disease therapy
6. Correction to: Lithium’s Gene Expression Profile, Relevance to Neuroprotection A cDNA Microarray Study
7. Monoamine Oxidases and Their Inhibitors
8. Treatment; Moussa B.H. Youdim
9. A sporadic Parkinson’s disease model via silencing of the ubiquitin–proteasome/E3 ligase component, SKP1A
10. Neuroprotection and Neurorestoration of Nigra Striatal Dopamine Neurons by Novel Multitarget Drugs, M30
11. Creation of a gene expression classifier for predicting Parkinson’s disease rate of progression
12. From Anti-Parkinson’s Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer’s Disease
13. Monoamine Oxidases and Their Inhibitors
14. Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases
15. A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist
16. The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging
17. Physiological and Clinical Aspects of Monoamine Oxidase
18. Correction to: Lithium’s Gene Expression Profile, Relevance to Neuroprotection A cDNA Microarray Study
19. N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change
20. Beneficial Effects of Multitarget Iron Chelator on Central Nervous System and Gastrocnemius Muscle in SOD1G93A Transgenic ALS Mice
21. Recent Advances in ALS Research: Perspectives for Personalized Clinical Application
22. Monoamine Oxidases and their Inhibitors
23. Multifunctional Neuroprotective Drugs for the Treatment of Alzheimer's Disease
24. Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis
25. Drugs with multiple CNS targets
26. Anti-Apoptotic Function of Propargylamines
27. Neuroprotective Actions of Green Tea Polyphenol, (-)-Epigallocatechin-3-Gallate in Models of Parkinson’s Disease: Gene Targets
28. TV3326, A Novel Cholinesterase and Mao Inhibitor : For Alzheimer’s disease with co-morbidity of Parkinson’s disease and depression
29. Neuroprotective Strategies in Parkinson’s Disease and Huntington’s Chorea : MPTP- and 3-NPA-Induced Neurodegeneration as Models
30. Contribution of Intracellular Non-Haem Iron, NF-kB Activation and Inflammatory Responses to Neurodegeneration in Parkinson’s Disease: Prospects for Neuroprotection
31. Brain Iron and other Trace Metals in Neurodegenerative Diseases
32. Neuromelanin may Mediate Neurotoxicity via its Interaction with Redox Active Iron
33. A novel neuroprotective cholinesterase-monoamine oxidase inhibitor for treatment of dementia and depression in Parkinson’s disease
34. Antioxidant and Cytoprotective Properties of Apomorphine
35. Iron and Neurotransmitter Function in the Brain
36. Iron and Parkinson’s Disease
37. Discussion: Session 5 — 8 P.M. - 8 February 1993
38. Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimerʼs disease
39. I
40. Neuropharmacological and Neurobiochemical Aspects of Iron Deficiency
41. Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus
42. Lithium’s Gene Expression Profile, Relevance to Neuroprotection A cDNA Microarray Study
43. Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism
44. Multi-target, Neuroprotective and Neurorestorative M30 Improves Cognitive Impairment and Reduces Alzheimer's-Like Neuropathology and Age-Related Alterations in Mice
45. Chronic treatment with serotonin reuptake inhibitor antidepressant (SSRI) combined with an antipsychotic regulates GABA-A receptor in rat prefrontal cortex
46. Understanding Parkinson’s Disease
47. Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death
48. Translocation and oligomerization of Bax is regulated independently by activation of p38 MAPK and caspase-2 during MN9D dopaminergic neurodegeneration
49. Site-Activated Chelators Derived from Anti-Parkinson Drug Rasagiline as a Potential Safer and More Effective Approach to the Treatment of Alzheimer’s Disease
50. Limited Potentiation of Blood Pressure in Response to Oral Tyramine by the Anti-Parkinson Brain Selective Multifunctional Monoamine Oxidase-AB Inhibitor, M30
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.